Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Hennion & Walsh Asset Management Inc.

Hennion & Walsh Asset Management Inc. grew its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 20.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,645 shares of the biotechnology company's stock after purchasing an additional 1,476 shares during the period. Hennion & Walsh Asset Management Inc.'s holdings in Axon Enterprise were worth $4,547,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Merit Financial Group LLC lifted its holdings in shares of Axon Enterprise by 160.5% during the 1st quarter. Merit Financial Group LLC now owns 14,535 shares of the biotechnology company's stock worth $7,645,000 after acquiring an additional 8,956 shares during the period. NBC Securities Inc. lifted its holdings in shares of Axon Enterprise by 119,666.7% during the 1st quarter. NBC Securities Inc. now owns 3,593 shares of the biotechnology company's stock worth $1,889,000 after acquiring an additional 3,590 shares during the period. Czech National Bank lifted its holdings in shares of Axon Enterprise by 5.9% during the 1st quarter. Czech National Bank now owns 16,638 shares of the biotechnology company's stock worth $8,751,000 after acquiring an additional 931 shares during the period. Rhumbline Advisers lifted its holdings in shares of Axon Enterprise by 3.7% during the 1st quarter. Rhumbline Advisers now owns 151,787 shares of the biotechnology company's stock worth $79,832,000 after acquiring an additional 5,428 shares during the period. Finally, Marion Wealth Management lifted its holdings in shares of Axon Enterprise by 13.1% during the 1st quarter. Marion Wealth Management now owns 459 shares of the biotechnology company's stock worth $241,000 after acquiring an additional 53 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

AXON has been the topic of several research reports. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. Needham & Company LLC raised their price target on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Barclays raised their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Finally, Bank of America raised their price target on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $699.55.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 9,000 shares of the stock in a transaction on Monday, May 12th. The shares were sold at an average price of $683.31, for a total transaction of $6,149,790.00. Following the transaction, the president now directly owns 308,714 shares in the company, valued at $210,947,363.34. This represents a 2.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Michael Garnreiter sold 87 shares of the stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $760.00, for a total transaction of $66,120.00. Following the transaction, the director now owns 24,653 shares in the company, valued at $18,736,280. This trade represents a 0.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,969 shares of company stock worth $29,909,594 in the last ninety days. 4.40% of the stock is owned by insiders.

Axon Enterprise Stock Up 0.4%

Shares of AXON stock traded up $3.49 on Friday, hitting $791.85. The stock had a trading volume of 443,537 shares, compared to its average volume of 731,575. The firm has a market capitalization of $61.65 billion, a price-to-earnings ratio of 204.61, a P/E/G ratio of 5.17 and a beta of 1.29. The stock's 50 day moving average is $643.89 and its 200-day moving average is $616.49. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a 52-week low of $278.24 and a 52-week high of $798.16.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The firm had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. During the same period in the prior year, the firm posted $1.15 EPS. The firm's revenue was up 31.3% compared to the same quarter last year. As a group, research analysts expect that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.